Blue Fin Capital’s Medtronic MDT Stock Holding History

Blue Fin Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,938	Closed	-$215K	–	137
2022 Q1	$215K	Hold	1,938	–	–	0.06%	129
2021 Q4	$200K	Sell	1,938 -78	-4%	-$9.03K	0.06%	131
2021 Q3	$252K	Sell	2,016 -337	-14%	-$43.6K	0.08%	118
2021 Q2	$292K	Sell	2,353 -100	-4%	-$12.6K	0.09%	106
2021 Q1	$289K	Sell	2,453 -141	-5%	-$16.5K	0.1%	102
2020 Q4	$303K	Buy	2,594 +46	+2%	+$5.06K	0.11%	96
2020 Q3	$264K	Sell	2,548 -176	-6%	-$17.7K	0.11%	99
2020 Q2	$249K	Sell	2,724 -383	-12%	-$36.7K	0.11%	101
2020 Q1	$280K	Sell	3,107 -586	-16%	-$62.3K	0.15%	95
2019 Q4	$418K	Buy	3,693 +692	+23%	+$75.9K	0.2%	96
2019 Q3	$325K	Buy	3,001 +3	+0.1%	+$313	0.17%	105
2019 Q2	$291K	Buy	2,998 +487	+19%	+$44.5K	0.15%	111
2019 Q1	$228K	Buy	+2,511	New	+$225K	0.12%	120
2017 Q3	–	Sell	-2,435	Closed	-$216K	–	130
2017 Q2	$216K	Sell	2,435 -491	-17%	-$41.4K	0.14%	126
2017 Q1	$236K	Sell	2,926 -200	-6%	-$15.6K	0.14%	122
2016 Q4	$222K	Buy	+3,126	New	+$246K	0.15%	123

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blue Fin Capital's MDT Position: Q2 2022 in Review

Blue Fin Capital sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,938 shares — an estimated $215K sold.

Blue Fin Capital first reported a position in MDT in Q4 2016 and held it in 16 quarters. The position peaked at $418K in Q4 2019. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Blue Fin Capital reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Blue Fin Capital sold 1,938 Medtronic shares in Q2 2022, an estimated $215K.
Blue Fin Capital first reported a position in Medtronic in Q4 2016 and held it in 16 quarters.
Blue Fin Capital's Medtronic position peaked at $418K in Q4 2019.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Blue Fin Capital's 13F filing for Q2 2022, filed 8 Aug 2022.